Safe reversal. 2. Atropine-neostigmine mixture: an electrocardiographic study.
D000759:Adjuvants, Anesthesia / Q000494:pharmacology*; D000293:Adolescent; D000328:Adult; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D001285:Atropine / Q000494:pharmacology*; D002245:Carbon Dioxide / Q000097:blood; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006985:Hyperventilation; D007023:Hypotension, Controlled; D007223:Infant; D007442:Intubation, Intratracheal; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000494:pharmacology*; D010425:Pentolinium Tartrate / Q000494:pharmacology; D011229:Preanesthetic Medication; D014403:Tubocurarine / Q000494:pharmacology
D000759:Adjuvants, Anesthesia; D002245:Carbon Dioxide; D009388:Neostigmine; D001285:Atropine; D010425:Pentolinium Tartrate; D014403:Tubocurarine